Am J Transplant, Volume 5, Suppl 3 Archives - Page 93 of 170 - ATC Abstracts

2015 American Transplant Congress
Validating Outcomes Reported to the Organ Procurement and Transplantation Network for Deceased Donor Kidney Recipients
V. Potluri,¹ C. Parikh,² I. Hall,² J. Ficek,² M. Doshi,³ I. Butrymowicz,² F. Weng,⁴ B. Schröppel,⁵ H. Thiessen-Philbrook,⁶ P. Reese.⁷
¹Lankenau Hospital, Philadelphia; ²Yale University School of Medicine, New Haven; ³Wayne State University, Detroit; ⁴Barnabas Health, Livingston, NJ; ⁵University Hospital, Ulm, Germany; ⁶Western University, Ontario, Canada; ⁷University of Pennsylvania, Philadelphia.
Data reported to the Organ Procurement and Transplantation Network (OPTN) is used in kidney transplant research, quality metrics and in policy development, but the accuracy…
2015 American Transplant Congress
Prospective, 6 Month, Open Label, Conversion Study from Mycophenolate Mofetyl to Mycophenolic Acid Evaluating the Severity of Gastro-Intestinal Symptoms and Mycophenolic Acid Urinary Metabolite as a Surrogate Marker of Plasmatic Area Under the Curve
D. Tran,¹ A. Boucher,¹ L. Senécal,¹ V. Pichette,¹ F. Leblond,² S. Collette.¹
¹Nephrology, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada; ²Research Center, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Introduction: Treatment with mycophenolate mofetil (MMF) often results in adverse gastro-intestinal (GI) events, which can lead to dose reductions that in turn can increase the…
2015 American Transplant Congress
Outbreak of Pandemic Influenza A (H1N1pdm) in a Kidney Transplant Unit – The Protective Effect of Vaccination
I. Helanterä,¹ V.-J. Anttila,² M. Lappalainen,³ M. Lempinen,¹ H. Isoniemi.¹
¹Department of Transplant and Liver Surgery, Helsinki University Central Hospital, Helsinki, Finland; ²Department of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland; ³Department of Virology, Helsinki University Central Hospital, Helsinki, Finland.
Background: Seasonal influenza vaccination is recommended for patients with end-stage renal disease, although the efficacy of the vaccination among these patients is unknown. We characterize…
2015 American Transplant Congress
Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy
E. Jolly,¹ C. Taylor,² H. Morgan,² S. Peacock,² M. Clatworthy,¹ N. Torpey.¹
¹Division of Renal Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom; ²Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Aims: Screening for HLA-specific antibodies (Ab) is routine for patients on kidney transplant waiting lists, and HLA antigens to which a patient has detectable Ab…
2015 American Transplant Congress
Consideration of the Futility of Transplant: 50% Mortality at 5 Years
S. Asrani, G. Saracino, J. O'Leary, G. Klintmalm, J. Trotter.
Baylor University Medical Center, Dallas, TX.
Introduction: Transplant recipients are globally sicker at the time of liver transplantation (LT) in the current era. We sought to devise and validate a model…
2015 American Transplant Congress
Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir
S. Dulanya, A. Anamisis, D. Tsapepas.
Department of Pharmacy, New York Presbyterian Hospital, New York City, NY.
Cytomegalovirus (CMV) is an opportunistic infection responsible for profound morbidity and mortality among solid organ transplant recipients. A donor and recipient's CMV IgG serostatus influences…
2015 American Transplant Congress
Birth Weight as a Marker of Nephron Mass: Predicting Living Kidney Donor Outcomes
T. Schachtner,^1,2 P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charité Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
It has been demonstrated that low birth weights give rise to a reduction in nephron number and low glomerular size in the postnatal kidney. Oligonephropathy…
2015 American Transplant Congress
Matching of Recipient and Donor Age Is the Most Powerful Risk Factor Affecting to Long-Term Graft Survival and Function
J. Lee,^1,2 Y. Lee,² J. Lee,^1,2 D. Joo,^1,2 K. Huh,^1,2 S. Kim,^1,2 Y. Kim,^1,2 M. Kim.^1,2
¹Department of Tranplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; ²The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.
Recipient age and donor age were typical non-immunologic parameters affecting to graft survival rate (GSR). Using more than 3,000 cases of living donor transplantation database…
2015 American Transplant Congress
Anti-Thymocyte Globulin Induction in Infected Mechanical Circulatory Support Patients: Is It Safe?
G. Jamero, J. Moriguchi, L. Czer, M. Kittleson, S. Siddiqui, F. Liou, D. Arman, L. Lam, D. Chang, P. Zakowski, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: The use of mechanical circulatory assist devices (MCSD) have been increasing over the past several years. Driveline infections (DLI) are one of the most…
2015 American Transplant Congress
Effect of Donor Age On Pancreas Transplantation Outcome
A. Rathnasamy Muthusamy,¹ G. Vrakas,¹ S. Mittal,¹ S. Reddy,¹ I. Quiroga,¹ J. Gilbert,¹ R. Ploeg,² E. Sharples,¹ S. Sinha,¹ A. Vaidya,¹ P. Friend.²
¹Transplant Surgery, Churchill Hospital, Oxford, United Kingdom; ²Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.
The global increase in the average donor age over the last decade has resulted in widespread acceptance of pancreases from older donors for transplantation. This…